Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcos de Lima

Showing results (61-70 of 321) with videos related to

Pageof 33
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|November 1, 2011
Allogeneic stem cell transplantation for chronic myeloid leukemia resistant to tyrosine kinase inhibitorsRichard Champlin, Elias Jabbour, Partow Kebriaei, et al.
Leukemia|May 26, 2020
Racial and age-related disparities in early mortality affect the outcomes of multiple myeloma patientsFahrettin Covut, James Joseph Driscoll, Brenda Cooper, et al.
Revista Brasileira De Hematologia E Hemoterapia|October 11, 2012
The significance of major and stable molecular responses in chronic myeloid leukemia in the tyrosine kinase inhibitor eraIlana Zalcberg Renault, Vanesa Scholl, Rocio Hassan, et al.
Blood Advances|February 24, 2026
Successful engraftment in myeloablative transplant with cadaveric bone marrow after sudden unavailability of living donorSumithira Vasu, Sarah Wall, Karilyn Larkin, et al.
Frontiers in Oncology|June 26, 2024
Late events after anti-CD19 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphomaAna Costa Cordeiro, George Durisek, Marjorie Vieira Batista, et al.
Current Hematologic Malignancy Reports|December 31, 2010
The role of transplantation in diffuse large B-cell lymphoma: the impact of rituximab plus chemotherapy in first-line and relapsed settingsCelso Arrais Rodrigues, Poliana Alves Patah, Yana A S Novis, et al.
Brazilian Journal of Otorhinolaryngology|August 19, 2006
Self-medication profile of ENT patientsAlexandre Barbosa Servidoni, Liliane Coelho, Marcos de Lima Navarro, et al.
Blood|October 14, 2006
Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS)Elihu Estey, Marcos de Lima, Raoul Tibes, et al.
Revista Brasileira De Hematologia E Hemoterapia|March 9, 2017
Isolated skin relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic stem cell transplantMasumi Ueda, Carlos Silva, Linda Baer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2009
Fludarabine-melphalan conditioning for AML and MDS: alemtuzumab reduces acute and chronic GVHD without affecting long-term outcomesKoen van Besien, Rangesh Kunavakkam, Gaby Rondon, et al.
Pageof 33

Showing results (61-70 of 321) with videos related to

Sort By:
Pageof 33
Clinical Lymphoma, Myeloma & Leukemia|November 1, 2011
Allogeneic stem cell transplantation for chronic myeloid leukemia resistant to tyrosine kinase inhibitorsRichard Champlin, Elias Jabbour, Partow Kebriaei, et al.
Leukemia|May 26, 2020
Racial and age-related disparities in early mortality affect the outcomes of multiple myeloma patientsFahrettin Covut, James Joseph Driscoll, Brenda Cooper, et al.
Revista Brasileira De Hematologia E Hemoterapia|October 11, 2012
The significance of major and stable molecular responses in chronic myeloid leukemia in the tyrosine kinase inhibitor eraIlana Zalcberg Renault, Vanesa Scholl, Rocio Hassan, et al.
Blood Advances|February 24, 2026
Successful engraftment in myeloablative transplant with cadaveric bone marrow after sudden unavailability of living donorSumithira Vasu, Sarah Wall, Karilyn Larkin, et al.
Frontiers in Oncology|June 26, 2024
Late events after anti-CD19 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphomaAna Costa Cordeiro, George Durisek, Marjorie Vieira Batista, et al.
Current Hematologic Malignancy Reports|December 31, 2010
The role of transplantation in diffuse large B-cell lymphoma: the impact of rituximab plus chemotherapy in first-line and relapsed settingsCelso Arrais Rodrigues, Poliana Alves Patah, Yana A S Novis, et al.
Brazilian Journal of Otorhinolaryngology|August 19, 2006
Self-medication profile of ENT patientsAlexandre Barbosa Servidoni, Liliane Coelho, Marcos de Lima Navarro, et al.
Blood|October 14, 2006
Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS)Elihu Estey, Marcos de Lima, Raoul Tibes, et al.
Revista Brasileira De Hematologia E Hemoterapia|March 9, 2017
Isolated skin relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic stem cell transplantMasumi Ueda, Carlos Silva, Linda Baer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2009
Fludarabine-melphalan conditioning for AML and MDS: alemtuzumab reduces acute and chronic GVHD without affecting long-term outcomesKoen van Besien, Rangesh Kunavakkam, Gaby Rondon, et al.
Pageof 33